Page 271 - Personalised medicine of fluoropyrimidines using DPYD pharmacogenetics Carin Lunenburg

SUPPLEMENT CHAPTER 10
Comparison of four phenotyping assays for predicting dihydropyrimidine dehydrogenase (DPD) deficiency and severe fluoropyrimidine-induced toxicity: a clinical study
Manuscript in preparation
Carin A.T.C. Lunenburg*, Linda M. Henricks*, Femke M. de Man*, Didier Meulendijks, André B.P. van Kuilenburg, Jan Gerard Maring, Maurice C. van Staveren, Niels de Vries, Hilde Rosing, Jos H. Beijnen, Dick Pluim, Anil Modak, Alexander L.T. Imholz, Jan H.M. Schellens, Jesse J. Swen, Hans Gelderblom, Annemieke Cats, Ron H.J. Mathijssen, Henk-Jan Guchelaar *Contributed equally
Please note that this manuscript contains confidential information, since these preliminary results have not yet been published. The results presented here are not under consideration for publication and have not been made publicly available